EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Impact of COVID-19 Infection on Pancreato-Biliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography

Briette Karanfilian, Amy Tyberg, Avik Sarkar, Haroon M Shahid, Alexa Simon, Karoline Reinoso, Amol Bapaye, Ashish Gandhi, Harshal P Gadhikar, Shivangi Dorwat, Hameed Raina, Jaseem Ansari und 14 weitere

Digestive Diseases and Sciences · 2024

DOI: 10.1007/s10620-024-08454-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Briette Karanfilian und 25 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA. Hauptthemen laut MEDLINE: Biliary Tract Diseases, Cholangiopancreatography, Endoscopic Retrograde, COVID-19, Pancreatic Diseases. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Viral infections are known to impact the pancreato-biliary system; however, there are limited data showing that the same is true of COVID-19. Endoscopic retrograde cholangiopancreatography (ERCP) can safely be performed in patients with COVID-19 infection, but outcomes of patients with COVID-19 infections and concomitant pancreatic and biliary disease requiring endoscopic intervention are unknown. AIMS: This study aims to evaluate the severity of pancreaticobiliary diseases and post-ERCP outcomes in COVID-19 patients. METHODS: Patients with pancreato-biliary disease that required inpatient ERCP from five centers in the United States and South America between January 1, 2020, and October 31, 2020 were included. A representative cohort of patients from each month were randomly selected from each site. Disease severity and post-ERCP outcomes were compared between COVID-19 positive and COVID-19 negative patients. RESULTS: A total of 175 patients were included: 95 COVID positive and 80 COVID negative. Mean CTSI score for the patients who had pancreatitis was higher in COVID-positive cohort by 3.2 points (p < .00001). The COVID-positive group had more cases with severe disease (n = 41) versus the COVID-negative group (n = 2) (p < .00001). Mortality was higher in the COVID-19 positive group (19%) compared to COVID-negative group (7.5%) even though the COVID-19-negative group had higher incidence of malignancy (n = 17, 21% vs n = 7, 7.3%) (p = 0.0455). CONCLUSIONS: This study shows that patients with COVID infection have more severe pancreato-biliary disease and worse post-ERCP outcomes, including longer length of stay and higher mortality rate. These are important considerations when planning for endoscopic intervention. CLINICALTRIALS: gov: (NCT05051358).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary Tract DiseasesCholangiopancreatography, Endoscopic RetrogradeCOVID-19Pancreatic DiseasesAgedFemaleHumansMaleMiddle AgedLength of StayRetrospective StudiesSARS-CoV-2Severity of Illness IndexUnited States

Stichwörter der Autor:innen

COVIDERCPEndoscopic interventionEndoscopic retrograde cholangiopancreatographyPancreatico-biliaryPancreatitis

Autor:innen und Institutionen

  • Endoscopy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA.
  • Pune Hospital, Pune, India.
  • Borland Groover Clinic, Jacksonville, FL, USA.
  • Posadas, Posadas, Argentina.
  • IECED, Guayaquil, Ecuador.
  • Universidad de Ribeirao Preto, Ribeirao Preto, SP, Brazil.

Zitieren

APA

Karanfilian, B., Tyberg, A., Sarkar, A., Shahid, H. M., Simon, A., Reinoso, K., Bapaye, A., Gandhi, A., Gadhikar, H. P., Dorwat, S., Raina, H., Ansari, J., Nieto, J., Qadir, N., Porfilio, M. G., Arevalo-Mora, M., Puga-Tejada, M., Alcivar-Vasquez, J., Robles-Medranda, C., …, & Kahaleh, M. (2024). Impact of COVID-19 Infection on Pancreato-Biliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08454-1

Vancouver

Karanfilian B, Tyberg A, Sarkar A, Shahid HM, Simon A, Reinoso K, et al. Impact of COVID-19 Infection on Pancreato-Biliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08454-1

BibTeX
@article{Karanfilian2024,
  author = {Karanfilian, Briette and Tyberg, Amy and Sarkar, Avik and Shahid, Haroon M and Simon, Alexa and Reinoso, Karoline and Bapaye, Amol and Gandhi, Ashish and Gadhikar, Harshal P and Dorwat, Shivangi and Raina, Hameed and Ansari, Jaseem and Nieto, Jose and Qadir, Nadim and Porfilio, Maria G and Arevalo-Mora, Martha and Puga-Tejada, Miguel and Alcivar-Vasquez, Juan and Robles-Medranda, Carlos and Ardengh, Jose Celso and Bareket, Romy and Liao, Kelvin and Patel, Roohi and Pimpinelli, Sophia and Gaidhane, Monica and Kahaleh, Michel},
  title = {Impact of COVID-19 Infection on Pancreato-Biliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography},
  journal = {Digestive Diseases and Sciences},
  year = {2024},
  doi = {10.1007/s10620-024-08454-1}
}
Kostenlos starten →